Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ekwxCfbwocfCcjeFHCdf

February 18, 2013
Sign upForwardArchiveAdvertise
 

  Top Stories 
 
  • PET/MR shows promise, challenges for cardiac imaging
    Hybrid PET/MR imaging offers great potential as an effective cardiac imaging tool because of MRI's capability to yield better soft-tissue contrast without radiation exposure, according to a report published in the Journal of Nuclear Medicine. "However, there are no obvious clinical indications or killer applications yet defined for the use of the integrated PET/MR instrumentation," the authors said. The complexity of workflow is greater with MRI than CT, and MRI is not suitable for all patients, posing some challenges for incorporating PET/MR in cardiac imaging. MolecularImaging.net (2/13) LinkedInFacebookTwitterEmail this Story
  • Higher heart risk seen with increased troponin rates in diabetes
    More than a fifth of stable diabetes patients examined showed slight elevations in cardiac troponin I levels and had a 50% increased risk of major adverse cardiac events over three years, researchers found. The results, published in Diabetes Care, "imply that any detectable cTnI level should warrant consideration for more globally aggressive risk-reduction efforts, including closer evaluation and long-term monitoring, and such intervention efforts may focus beyond glycemic-control measures," said researcher Dr. W.H. Wilson Tang. Medscape (free registration) (2/15) LinkedInFacebookTwitterEmail this Story
  • Other News
4 Essential Resources To Boost Revenue
CareCloud developed this guide to help physician practices across the US understand and improve financial performance. We believe that better health outcomes for Americans are more likely to be achieved when practices themselves are thriving and efficient. Download now.

  Medical Focus 
  • Analysis: Diclofenac's heart risks warrant caution
    Diclofenac, a nonsteroidal anti-inflammatory drug, was associated with an up to 63% higher risk of cardiovascular events and should be eliminated from essential-medicines lists, according to a meta-analysis published online in PLoS Medicine. Diclofenac was the most widely used NSAID in 15 countries, and its heart risk was comparable to that of rofecoxib, which was withdrawn from the market due to its cardiovascular toxicity. TheHeart.org (Montreal) (free registration) (2/13) LinkedInFacebookTwitterEmail this Story
  • Hours in ED may put heart patients in danger of PTSD
    Patients who waited in the emergency department for more than 11 hours with a heart attack or severe chest pain were at greater risk of heart disease-related post-traumatic stress disorder in the month after hospitalization, a study found. The findings, based on 135 heart patients admitted at a New York City hospital between 2009 and 2011, were published in the journal JAMA Internal Medicine. HealthDay News (2/11) LinkedInFacebookTwitterEmail this Story
  • Other News
5 positive ways to respond to negative comments.
Social media is a great way to connect with your customers, but what do you do when the conversation takes a negative turn? With 5 tips, you can learn how to positively respond and help direct the conversation. Read the article and learn the 5 ways to respond positively.

  Regulatory & Policy 
  • Legislative committee hears ideas on replacing SGR
    A House Energy and Commerce Health Subcommittee hearing Thursday discussed issues surrounding a potential repeal of the sustainable growth rate formula, including concerns about how to pay for eliminating the SGR and how to measure and reward quality. Committee members and other health experts questioned whether models such as accountable care organizations, which tie pay to quality and outcomes, will work for rural or small-practice physicians. MedPage Today (free registration) (2/14) LinkedInFacebookTwitterEmail this Story
  • Exchanges will be ready by Oct. 1, HHS tells Congress
    HHS official Gary Cohen assured a Senate panel that all 50 state health insurance markets would meet the enrollment deadline of Oct. 1. Senators from both parties raised concerns about how affordable plans on the exchanges will be. Reuters (2/14) LinkedInFacebookTwitterEmail this Story
  ASNC News 
  • Resources for getting your scientific paper published
    Now that ASNC2013 has announced its Call for Abstracts, we recommend you take advantage of resources to help you get your paper published. Springer, a leading global scientific publisher and the publisher of the Journal of Nuclear Cardiology, is working with Edanz, an English editing group for scientists. Edanz is designed to help authors, whose first language may or may not be English, publish their original works. The editors can help with English editing, review editing, expert scientific review, abstract development, cover letter development and much more. If you have written an original article and would like to submit it to the Call for Abstracts for ASNC2013 or the Journal of Nuclear Cardiology, Edanz will help you submit your paper. Take advantage of this link to Edanz to get a 10% author discount! Springer also offers additional resources on its website — learn more. LinkedInFacebookTwitterEmail this Story
Learn more about ASNC ->ASNC Home | Join ASNC | Education and Meetings
Annual Meeting | Journal of Nuclear Cardiology

  SmartQuote 
Paradise is here or nowhere: you must take your joy with you or you will never find it."
--Orison Swett Marden,
American author


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Meryl Harold (202) 407-7828
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent ASNC SmartBrief Issues:   Lead Editor:  Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information